Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Propofol

Research Leaders

5 sponsors active, led by Seoul National University Hospital

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed4

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 4 completed trials

Clinical Trials (4)

Research Network

Common Treatments

  • Propofol2
  • Eeg Monitoring1
  • Titration Induction To Propofol1

Active Sponsors

  • Seoul National University Hospital1
  • Lihong Chen1
  • Universidad del Desarrollo1
  • Pontificia Universidad Catolica de Chile1
  • West China Hospital1

Top Investigators

Activity Timeline